DISTRIBUTION OF ERYTHROCYTE ANTIGENS AND ALLOIMMUNIZATION INDEX OF CARDIAC SURGERY PATIENTS IN THE SOUTH FEDERAL DISTRICT AND THE NORTHERN CAUCASUS FEDERAL DISTRICT
https://doi.org/10.25837/HAT.2019.49.58.002
Abstract
Introduction. Massive transfusions of allogenic erythrocytes boost risk of post-transfusion reactions and complications for recipients, among them most severe are the immune hemolytic complications. Ensuring the safety of blood transfusion maintenance of high-tech operations on the heart and blood vessels is an important task.
Objective: An analysis of the distribution of erythrocyte antigens of AB0 and RH systems among patients and the incidence of anti-erythrocyte antibodies. Materials and methods. 13,948 patients’ blood samples were examined in 2014— 2016. In the first half of 2017, antibodies (secondary screening) were further examined on days 5—7 and 12—14 after blood transfusion of 51 patients with massive transfusions and/or transfusions of donor RBC containing at least one antigen not found in the recipient’s (C, c, E, e). Immunological studies and selection of a donor-recipient pairs were performed by highly sensitive methods in gel cards of the diagnostic system Diagnostic Grifols SA (Spain).
Results. The study showed that the use of the gel technique in antibodies screening increases their detectability by several times (from 0.15% to 0.75%). There were no significant differences in the distribution of AB0 blood groups between immunized and nonimmunized patients. The greatest number of alloimmunized patients is at the age from 50 to 70 years. Immune alloantibodies are more often detected in women (1.10%) and Rh-negative patients than in men (0.55%) and Rh-positive patients (0.45%). The study did not reveal the production of alloantibodies in patients on days 5—7 and 12—14 after blood transfusion , even at transfusion of RBC with nonshared antigens (C, c, E, e).
The conclusion. It is desirable to investigate the presence of anti-erythrocyte alloantibodies before each blood transfusion, especially if blood transfusion is performed later than 12—14 days after the previous one. It is advisable to keep medical records (an extract from the hospital) with the data on the transfusions of donor erythrocyte-containing medium with the indication of their phenotype.
About the Authors
L. G. MedyancevaRussian Federation
Astrakhan
S. I. Minaev
Russian Federation
Astrakhan
E. M. Chishieva
Russian Federation
Astrakhan
N. N. Levina
Russian Federation
Astrakhan
References
1. Mineeva NV, Pashkova IA, Krobinets II, Gavrovskaya SV, Sysoeva EA, Bodrova NN. Optimizing selection of compatible «donor—recipient» pairs: the role of antibody screening and erythrocyte antigens phenotyping in the blood transfusion recipients. Transfusiology (Transfuziologiya). 2015;16:52—9 (in Russian).
2. Mineeva NV. Human blood groups. Fundamentals of immunohematology. Russian Institute of Transfusiology and Hematology. St.Peterburg. 2004 (in Russian).
3. Zhiburt EB. Transfusiology: a textbook. Piter. St. Peterburg. 2002 (in Russian)
4. Zhiburt EB, Popova VI, Ivanova IV, Reyzman PV. Screening of antierythrocyte antibodies and other practical questions of immunoserology. Transfusiology (Transfuziologiya). 2004;5:72—9 (in Russian).
5. Medyanceva LG, Chishieva EM, Levina NN, Tarasov DG, Shashin SA. Phenotyping and screening of alloimmune antibodies as a pledge of immunological safety of blood transfusions. The Bulletin of Bakoulev Center Cardiovascular Diseases (Bulleten Nauchnogo tsentra serdechnososudistoi hirurgii im. Bakuleva). 2014;15:242 (in Russian).
6. Order of the Ministry of Health of the Russian Federation of 02.04.2013 № 183n «On approval the rules of the clinical use of blood and (or) its components». https://rg.ru/2013/08/28/donory-dok.html (in Russian).
7. Donskov SI, Gaponova TV. The risk and the prevention of posttransfusion complications caused by group antigen red blood cells. Bulletin of the Russian Blood Service (Vestnik sluzhby krovi Rossii). 2013;4:1—4 (in Russian).
8. Fanaskova EV, Gruzdeva OV, Galkovskaya LA, Galkovskaya NA, Kolmagorova EA, Goncharenko MV et al. Distribution of transfusionhazardous erythrocyte antigens and alloimmunization of cardiac patients and donors in the Kemerovo region. Russian Journal of Hematology and Transfusiology (Gematologiya i transfuziologiya). 2015;60:20—5 (in Russian).
9. Donskov SI, Kalandarov RS, Dubinkin IV. Distribution of dangerous antigens transfusion of red blood cells in the Russian Federation and neighboring countries. Bulletin of the Russian Blood Service (Vestnik sluzhby krovi Rossii). 2010;4:33—7 (in Russian).
Review
For citations:
Medyanceva L.G., Minaev S.I., Chishieva E.M., Levina N.N. DISTRIBUTION OF ERYTHROCYTE ANTIGENS AND ALLOIMMUNIZATION INDEX OF CARDIAC SURGERY PATIENTS IN THE SOUTH FEDERAL DISTRICT AND THE NORTHERN CAUCASUS FEDERAL DISTRICT. Russian journal of hematology and transfusiology. 2018;63(3):231-238. (In Russ.) https://doi.org/10.25837/HAT.2019.49.58.002